Clozapine pharmacokinetics studied with CYP1A2 knockout mice

被引：0
|
作者：
Aitchison, KJ [1 ]
Jann, MW [1 ]
Wolff, K [1 ]
Sakai, T [1 ]
Makoff, AJ [1 ]
Collier, DA [1 ]
Gonzalez, FJ [1 ]
Kerwin, RW [1 ]
机构：
[1] Inst Psychiat, Dept Psychol Med, Sect Clin Neuropharmacol, London SE5 8AF, England
来源：
SCHIZOPHRENIA RESEARCH | 2000年 / 41卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(00)90889-2
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
B164
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [1] Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice
    Aitchison, KJ
    Jann, MW
    Zhao, JH
    Sakai, T
    Zaher, H
    Wolff, K
    Collier, DA
    Kerwin, RW
    Gonzalez, FJ
    JOURNAL OF PSYCHOPHARMACOLOGY, 2000, 14 (04) : 353 - 359
  • [2] Role of CYP1A2 in caffeine pharmacokinetics and metabolism: Studies using mice deficient in CYP1A2
    Buters, JTM
    Tang, BK
    Pineau, T
    Gelboin, HV
    Kimura, S
    Gonzalez, FJ
    PHARMACOGENETICS, 1996, 6 (04): : 291 - 296
  • [3] Theophylline pharmacokinetics:: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice
    Derkenne, S
    Curran, CP
    Shertzer, HG
    Dalton, TP
    Dragin, N
    Nebert, DW
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (07): : 503 - 511
  • [4] Metabolic activation of phenanthrene by human and mouse cytochromes P450 and pharmacokinetics in CYP1A2 knockout mice
    Schober, Wolfgang
    Pusch, Gudrun
    Oeder, Sebastian
    Reindl, Heidi
    Behrendt, Heidrun
    Buters, Jeroen T. M.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 183 (01) : 57 - 66
  • [5] Nonresponse to clozapine and ultrarapid CYP1A2 activity - Clinical data and analysis of CYP1A2 gene
    Eap, CB
    Bender, S
    Sirot, EJ
    Cucchia, G
    Jonzier-Perey, M
    Baumann, P
    Allorge, D
    Broly, F
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (02) : 214 - 219
  • [6] Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice
    Kapelyukh, Y.
    Henderson, C. J.
    Scheer, N.
    Rode, A.
    Wolf, C. R.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (08) : 907 - 918
  • [7] Impact of Cyp1a2 or Ahr gene knockout in mice:: Implications for biomonitoring studies
    Talaska, G
    Ginsburg, D
    LaDow, K
    Puga, A
    Dalton, T
    Warshawsky, D
    TOXICOLOGY LETTERS, 2006, 162 (2-3) : 246 - 249
  • [8] The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine
    Eiermann, B
    Engel, G
    Johansson, I
    Zanger, UM
    Bertilsson, L
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (05) : 439 - 446
  • [9] Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine?
    Ruan, Can-Jun
    de Leon, Jose
    PHARMACOGENOMICS, 2020, 21 (06) : 369 - 373
  • [10] Role of CYP1A2 in the hepatotoxicity of acetaminophen:: Investigations using Cyp1a2 null mice
    Tonge, RP
    Kelly, EJ
    Bruschi, SA
    Kalhorn, T
    Eaton, DL
    Nebert, DW
    Nelson, SD
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 153 (01) : 102 - 108
12345